Search

Search Constraints

You searched for: Author/Creator Tseng, Chia-Lin

Search Results

11. 5: Biochemical Failure and Toxicity of Magnetic Resonance Imaging Dose Painting to Dominant Intraprostatic Lesion in Prostate High Dose Rate Brachytherapy. (October 2021)

12. 68: A Prospective Study of Mr-Guided Focal Salvage High Dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients. (October 2021)

13. 69: Dosimetric Comparison in Malignant Glioma Patients Clinically Treated on Hybrid Magnetic Resonance Imaging (MRI)-Linac (MRL) Versus Conventional Linac. (October 2021)

14. 80 Toxicity and Quality of Life Results from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer. (October 2019)

15. 83: Dose-Escalated Two-Fraction Spine Stereotactic Body Radiotherapy: 28 GY Versus 24 GY in 2 Daily Fractions. (September 2022)

16. 8: Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy. (October 2021)

17. Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients. (November 2021)

18. Chemical exchange saturation transfer MRI in central nervous system tumours on a 1.5 T MR-Linac. (September 2021)

20. Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis. (September 2020)